Hyperkalemia

Also known as: high potassium

Also relevant to Emergency & Critical Care

Free to read — no account needed. Sign in only to bookmark this disease and track your study progress.

United StatesNKF/AUA

No NKF/AUA guideline indexed for this condition yet.

Every entry is added by hand and cited to the issuing society, so a gap here means we have not verified one — not that none exists. Know the right one? Tell us.

EuropeERA/EAU (global: KDIGO)

Current

UKKA Clinical Practice Guideline: Treatment of Acute Hyperkalaemia in Adults

UK Kidney Association (UKKA) — national, not EU-wide · 2023

A national guideline on the emergency assessment and treatment of acute hyperkalaemia in adults, including severity grading and the sequence of protective, shifting and removal therapies.

UKKA lists 'Treatment of Acute Hyperkalaemia in Adults' among its current clinical practice guidelines. source
UKKA guidelines are prepared by its Clinical Practice Guidelines Committee, are editorially independent, and receive no external or commercial funding. source

Verify against original ↗

US vs EU key differences

No curated US/EU comparison yet for this disease.

What changed recently

EU2020 → 20232023-01-01
The 2023 UKKA update revised the 2020 hyperkalaemia guideline after an MHRA safety review of calcium gluconate, changing the dose and infusion rate advice for intravenous calcium salts. It also widened the role of the newer potassium binders sodium zirconium cyclosilicate and patiromer to moderate as well as severe acute hyperkalaemia, dropped calcium resonium from acute treatment, and modified blood glucose monitoring after the insulin-glucose regimen.
source ↗

See the full update feed for changes across every system.